24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo
- PMID: 31125679
- DOI: 10.1016/j.bbagen.2019.05.013
24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo
Abstract
Background: Epidemiological studies indicate high serum 25(OH)D3 is associated with increased survival in breast cancer patients. Pre-clinical studies attributed this to anti-tumorigenic properties of its metabolite 1α,25(OH)2D3. However, 1α,25(OH)2D3 is highly calcemic and thus has a narrow therapeutic window. Here we propose another metabolite, 24R,25(OH)2D3, as an alternative non-calcemic vitamin D3 supplement.
Methods: NOD-SCID-IL2γR null female mice with MCF7 breast cancer xenografts in the mammary fat pad were treated with 24R,25(OH)2D3 and changes in tumor burden and metastases were assessed. ERα66+ MCF7 and T47D cells, and ERα66- HCC38 cells were treated with 24R,25(OH)2D3in vitro to assess effects on proliferation and apoptosis. Effects on migration and metastatic markers were assessed in MCF7.
Results: 24R,25(OH)2D3 reduced MCF7 tumor growth and metastasis in vivo. In vitro results indicate that this was not due to an anti-proliferative effect; 24R,25(OH)2D3 stimulated DNA synthesis in MCF7 and T47D. In contrast, markers of invasion and metastasis were decreased. 24R,25(OH)2D3 caused dose-dependent increases in apoptosis in MCF7 and T47D, but not HCC38 cells. Inhibitors to palmitoylation, caveolae integrity, phospholipase-D, and estrogen receptors (ER) demonstrate that 24R,25(OH)2D3 acts on MCF7 cells through caveolae-associated, phospholipase D-dependent mechanisms via cross-talk with ERs.
Conclusion: These results indicate that 24R,25(OH)2D3 shows promise in treatment of breast cancer by stimulating tumor apoptosis and reducing metastasis.
General significance: 24R,25(OH)2D3 regulates breast cancer cell survival through ER-associated mechanisms similar to 24R,25(OH)2D3 effects on chondrocytes. Thus, 24R,25(OH)2D3 may modulate cell survival in other estrogen-responsive cell types, and its therapeutic potential should be investigated in ER-associated pathologies.
Keywords: 24R,25-dihydroxyvitamin D(3); Breast cancer; Estrogen receptor α; Estrogen-receptor positive breast cancer; Natural cancer therapies; Vitamin D(3).
Published by Elsevier B.V.
Similar articles
-
The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer.Mol Cancer Res. 2021 Jan;19(1):99-111. doi: 10.1158/1541-7786.MCR-20-0169. Epub 2020 Oct 20. Mol Cancer Res. 2021. PMID: 33082240 Free PMC article.
-
24R,25-dihydroxyvitamin D3 modulates tumorigenicity in breast cancer in an estrogen receptor-dependent manner.Steroids. 2019 Oct;150:108447. doi: 10.1016/j.steroids.2019.108447. Epub 2019 Jul 11. Steroids. 2019. PMID: 31302113 Review.
-
Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.J Cell Biochem. 2003 Dec 15;90(6):1207-23. doi: 10.1002/jcb.10716. J Cell Biochem. 2003. PMID: 14635194
-
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.Clin Cancer Res. 2000 Aug;6(8):3371-9. Clin Cancer Res. 2000. PMID: 10955825
-
Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism.Crit Rev Oral Biol Med. 2002;13(2):143-54. doi: 10.1177/154411130201300205. Crit Rev Oral Biol Med. 2002. PMID: 12097357 Review.
Cited by
-
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.Cancers (Basel). 2021 Oct 3;13(19):4972. doi: 10.3390/cancers13194972. Cancers (Basel). 2021. PMID: 34638457 Free PMC article. Review.
-
Synthesis of Deuterium-Labeled Vitamin D Metabolites as Internal Standards for LC-MS Analysis.Molecules. 2022 Apr 9;27(8):2427. doi: 10.3390/molecules27082427. Molecules. 2022. PMID: 35458625 Free PMC article.
-
Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms.Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3349-3361. doi: 10.31557/APJCP.2024.25.10.3349. Asian Pac J Cancer Prev. 2024. PMID: 39471001 Free PMC article.
-
Prognostic role of vitamin D receptor in digestive system tumours: A systematic review and preliminary meta-analysis.PLoS One. 2023 Aug 10;18(8):e0289598. doi: 10.1371/journal.pone.0289598. eCollection 2023. PLoS One. 2023. PMID: 37561808 Free PMC article.
-
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.Int J Mol Sci. 2021 Mar 9;22(5):2781. doi: 10.3390/ijms22052781. Int J Mol Sci. 2021. PMID: 33803480 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical